General Practice Doctors in Stockton, CA Accepting Medicare

10 General Practice doctors found. Showing 1 - 10

Henry Bahgat Selim, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3279 Lakeshore Court, Stockton, CA 95219 Phone: 209-951-6550

Dr. Toan Hung Tran, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 4545 Georgetown Pl, C16, Stockton, CA 95207 Phone: 209-957-0641

Dr. Aziz Kamali, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 4505 Precissi Ln # 1, Stockton, CA 95207 Phone: 209-478-5533    Fax: 209-956-9180

Dr. Maynard F. Lang, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 782 East Harding Way, Stockton, CA 95205 Phone: 209-475-5500    Fax: 209-466-1982

Dr. Sanjeev Batra, DO General Practice Medicare: Medicare Enrolled Practice Location: 1307 N Commerce St, Stockton, CA 95202 Phone: 916-273-8262

Dr. Harbhajan Singh Shergill, MD General Practice Medicare: Medicare Enrolled Practice Location: 2701 E Hammer Ln, Ste 103, Stockton, CA 95210 Phone: 209-320-2650    Fax: 209-320-2653

Lien Huynh Thi Nguyen, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1545 Saint Marks Plz Ste 3, Stockton, CA 95207 Phone: 209-957-3901    Fax: 209-957-2857

Bradley Donald Tourtlotte, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 3663 Arch Rd, Suite 400, Stockton, CA 95215 Phone: 209-943-2202    Fax: 209-943-2209

Dr. Ngac Tien Tran, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 1545 Saint Marks Plz, Suite 1c, Stockton, CA 95207 Phone: 209-473-2833    Fax: 209-473-0435

Mr. Dumrong Jirasut, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 75 W March Lane, Suite H, Stockton, CA 95207 Phone: 209-477-4485    Fax: 209-477-4487

News Archive

Research provides more evidence that mRNA vaccines can protect mice against Zika virus

Vaccine developers have successfully protected mice against Zika by injecting synthetic messenger RNA that encodes for virus proteins into the animals.

FDA authorizes INDA for recombinant human C1 inhibitor in kidney transplantation

Biotech company Pharming Group NV has announced that the US Food and Drug Administration (FDA) has authorized a clinical study with recombinant human C1 inhibitor (rhC1INH) for the treatment of antibody-mediated rejection (AMR) in kidney transplantation. Dr. Hans Sollinger of the University of Wisconsin, Madison will conduct the clinical trial with rhC1INH under an Investigator IND from the FDA.

Changes in size of mitochondria in subset of brain cells could be key to maintaining blood sugar

Keeping blood sugar levels within a safe range is key to managing both type 1 and type 2 diabetes. In a new finding that could lead to fewer complications for diabetes patients, Yale School of Medicine researchers have found that changes in the size of mitochondria in a small subset of brain cells play a crucial role in safely maintaining blood sugar levels.

New Mosby's Index now available in easier-to-navigate format

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the revamping of Mosby's Index, the most robust journal abstracts and indexing database available for nurses and other healthcare professionals.

Oncolytics Biotech receives U.K. MHRA approval for REOLYSIN combination Phase 3 trial

Oncolytics Biotech Inc. today announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers. This is the same trial that the Company previously reached an agreement on with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process.

Read more Medical News

› Verified 7 days ago